Detalles de la búsqueda
1.
Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium "Long-Acting Injectables" Working Group.
Pharm Res
; 40(7): 1601-1631, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36811809
2.
Safety and Pharmacokinetics of Islatravir in Individuals with Severe Renal Insufficiency.
Antimicrob Agents Chemother
; 66(12): e0093122, 2022 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36346229
3.
Leveraging model-informed approaches for drug discovery and development in the cardiovascular space.
J Pharmacokinet Pharmacodyn
; 45(3): 355-364, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29353335
4.
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection.
J Acquir Immune Defic Syndr
; 92(4): 310-316, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36450129
5.
In Vitro Pharmacokinetic/Pharmacodynamic Modeling of HIV Latency Reversal by Novel HDAC Inhibitors Using an Automated Platform.
SLAS Discov
; 26(5): 642-654, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33427012
6.
Safety and Pharmacokinetics of Once-Daily Multiple-Dose Administration of Islatravir in Adults Without HIV.
J Acquir Immune Defic Syndr
; 88(3): 314-321, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34651606
7.
Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial.
Nat Med
; 27(10): 1712-1717, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34608329
8.
The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group.
Clin Pharmacokinet
; 58(7): 899-910, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30810947
9.
A Phase Ib Randomized Controlled Study to Evaluate the Effectiveness of a Single-Dose of the NR2B Selective N-Methyl-D-Aspartate Antagonist MK-0657 on Levodopa-Induced Dyskinesias and Motor Symptoms in Patients With Parkinson Disease.
Clin Neuropharmacol
; 40(6): 255-260, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29059133
10.
Development of in vitro-in vivo correlation for extended-release niacin after administration of hypromellose-based matrix formulations to healthy volunteers.
J Pharm Sci
; 103(11): 3713-3723, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25256703
Resultados
1 -
10
de 10
1
Próxima >
>>